Euclidean Capital

Latest statistics and disclosures from Euclidean Capital's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are VEU, VTV, INDA, ORIC, FHTX, and represent 97.62% of Euclidean Capital's stock portfolio.
  • Added to shares of these 1 stock: VEU (+$19M).
  • Reduced shares in these 2 stocks: , RAPT.
  • Sold out of its positions in RAPT, SPY.
  • Euclidean Capital was a net buyer of stock by $13M.
  • Euclidean Capital has $392M in assets under management (AUM), dropping by 6.19%.
  • Central Index Key (CIK): 0001825034

Tip: Access up to 7 years of quarterly data

Positions held by Euclidean Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Euclidean Capital

Euclidean Capital holds 10 positions in its portfolio as reported in the March 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Vanguard Intl Equity Index F Allwrld Ex Us (VEU) 62.1 $244M +8% 3.2M 75.10
 View chart
Vanguard Index Fds Value Etf (VTV) 26.0 $102M 520k 196.20
 View chart
Ishares Tr Msci India Etf (INDA) 4.4 $17M 370k 46.84
 View chart
Oric Pharmaceuticals (ORIC) 3.2 $13M 989k 12.67
 View chart
Foghorn Therapeutics (FHTX) 1.9 $7.5M 1.6M 4.78
 View chart
Pmv Pharmaceuticals (PMVP) 0.8 $3.3M 2.6M 1.24
 View chart
Alector (ALEC) 0.7 $2.8M 1.3M 2.15
 View chart
Surrozen Com New (SRZN) 0.7 $2.6M 88k 29.13
 View chart
Tenaya Therapeutics (TNYA) 0.2 $703k 1.0M 0.69
 View chart
Surrozen *w Exp 08/01/203 (SRZNW) 0.0 $2.7k 171k 0.02
 View chart

Past Filings by Euclidean Capital

SEC 13F filings are viewable for Euclidean Capital going back to 2020

View all past filings